Recent articles about Japan 日本関連英文記事 Vol.38(U.S.-Japan virtual summit, U.S. ambassador to Japan, etc. 日米首脳オンライン会談、米駐日大使 など)


 https://twitter.com/Suntimes/status/1483862069862703106
 https://twitter.com/ShingetsuNews/status/1480342000843235332


 https://twitter.com/tfiglobal/status/1485153358118014983

Northern Europe 北欧 Vol.11(Norway ノルウェー Vol.3)

続き cont.


https://twitter.com/AkerWind/status/1481295011887132675


https://twitter.com/GWECGlobalWind/status/1456653084390723597


https://twitter.com/MoaathFawwaz/status/1436027472844234784
https://twitter.com/abb_automation/status/1436238055741009923


https://twitter.com/Vallourec/status/1410965889353195530


https://twitter.com/NorwayinUK/status/1329365613307949056


https://twitter.com/ChidiObihara/status/1297980692899430406

以上です。

Northern Europe 北欧 Vol.10(Norway ノルウェー Vol.2)

続き cont.


https://twitter.com/Eurometaux/status/1414547764671913987


https://twitter.com/RonnaugSS/status/1350211016471293952


https://twitter.com/SAPIndia/status/1384439200846520324


https://twitter.com/viktoriabourbon/status/1341330010108551171


https://twitter.com/UKinNorway/status/1217529083254329344
https://twitter.com/cemasys/status/1205120927085801473


https://twitter.com/matthewpskelton/status/1275791091070009346

Northern Europe 北欧 Vol.9(Norway ノルウェー Vol.1)

Almost all the below tweets/links are in English.

取り急ぎ以下貼っておきます。

Norway Vol.1 (lifeinnorway, TheLocalNorway, norwaynews, UniOslo, etc.)

Norway Vol.2 (NorskHydroASA) Norsk Hydro

Norway Vol.3 (TelenorGroup) Telenor

Norway Vol.4 (DNBMarkets) DNB

Northern Europe Vol.6

以下、順に、
1:@UiO_LifeSci、@nationalpost,@business、@norwaynews
2:@NorskHydroASA
3:@TelenorGroup2枚
4:@oddmundberg
Norway1 SPARK Norway project lays the foundation for a new biotech company @UiO_LifeSci
Norway1 Cashlessness may have gone too far in Norway @nationalpost,@business
Norway1 electricity-bills @norwaynews
Norway2 NorskHydroASA
Norway3 Optimize everything @Telenor
Norway3 5G @Telenor
Norway4 Home-prices @oddmundberg @ DNB

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

企業名などを入力検索して出て来たツイート


https://twitter.com/Equinor/status/1436050282639675393


https://twitter.com/TimBuckleyIEEFA/status/1304977128702660610


https://twitter.com/yara/status/1484534971629027332


https://twitter.com/glmforum/status/1476810440936153104


https://twitter.com/stholsether/status/1483074595926204418

Recent articles about Japan 日本関連英文記事 Vol.37(incl Omicron variant, Tonga eruption オミクロン株、トンガ噴火含む)


cf. World Vol.224 (Tonga eruption)


https://twitter.com/bernamaradio/status/1482555970564009987


https://twitter.com/SeismoSue/status/1482804929387454469


https://twitter.com/wef/status/1379071327043252226


https://twitter.com/la_resistensia_/status/1457736995912962051

#Coronavirus #コロナウイルス Vol.34(Omicron variant オミクロン株 – treatments, etc. 治療薬など)

All the below links are in English. Excerpts are on our own.

ご参考まで取り急ぎ以下貼っておきます。

cf.
World Vol.215 (coronavirus – Omicron variant)
UK Vol.189 (coronavirus – Omicron variant)

Pfizer Shares In Vitro Efficacy of Novel COVID-19 Oral Treatment Against Omicron Variant (01/18/2022) | @Pfizer
…the in vitro efficacy of nirmatrelvir, the active main protease (Mpro) inhibitor of PAXLOVID (nirmatrelvir [PF-07321332] tablets and ritonavir tablets), is maintained against the SARS-CoV-2 variant Omicron. …PAXLOVID has the potential to maintain plasma concentrations many-fold times higher than the amount required to prevent Omicron from replicating in cells. …
…PAXLOVID reduced risk of hospitalization or death by nearly 90% compared to placebo for high-risk patients when treated within five days of symptom onset…
Current VoCs * can be resistant to treatments that work by binding to the spike protein found on the surface of the SARS-CoV-2 virus. PAXLOVID, however, works intracellularly by binding to the highly conserved Mpro of the SARS-CoV-2 virus. Previous data have also indicated that PAXLOVID maintains in vitro efficacy against earlier and current VoCs, including Alpha, Beta, Gamma, Delta, Lambda, and Mu.
PAXLOVID is currently authorized for conditional or emergency use in several countries across the globe. Pfizer has submitted applications for regulatory approval or authorization to multiple regulatory agencies and anticipates further regulatory decisions to follow.
* VoCs = variants of concern

‘There are very limited treatments’: COVID outpatient treatments evaporate with omicron (w Video; 01/17/2022) | @WLWT
… The oral COVID-19 treatments from Pfizer and Merck are expected to be effective in treating outpatients, but manufacturing hasn’t ramped up to the point that the pill-form treatments are readily available. …

‘Omicron patients under 60 with no comorbidities can start symptomatic treatment with paracetamol’ (01/18/2022) | @IndianExpress
…a 30 per cent hospitalisation risk reduction with the use of molnupiravir. If someone above the age of 50 has a consistent fever for two days alongside two or three comorbidities, the doctor might prescribe them these antivirals. …
…there is no need to worry as these pills are not prescribed to children below the age of 18, or to patients who require hospitalization, or to pregnant women. “The pill must be administered within 72 hours of the onset of symptoms for patients in the high-risk population group, namely, hypertensives, diabetics, people on immunosuppressed medication, senior citizens, people with other ailments etc.”…

WHO adds new drugs to COVID treatments amid Omicron surge (14/01/2022) | @AJEnglish
… The drug baricitinib, which is also used to treat rheumatoid arthritis, is “strongly recommended” for patients with severe or critical COVID-19, in combination with corticosteroids…
The panel also gave a “conditional recommendation” for sotrovimab, an experimental monoclonal antibody treatment, for those with non-severe COVID-19 but at the very highest risk of hospital admission. Monoclonal antibodies are lab-created compounds that mimic the body’s natural defence mechanism. …
The “guidance adds to previous recommendations for the use of interleukin-6 receptor blockers and systemic corticosteroids for patients with severe or critical covid-19; conditional recommendations for the use of casirivimab-imdevimab (another monoclonal antibody treatment) in selected patients; and against the use of convalescent plasma, ivermectin and hydroxychloroquine in patients with covid-19 regardless of disease severity,” the WHO said in a statement. …
Baricitinib is produced by United States pharmaceutical giant Eli Lilly, and while generic versions are available in India and Bangladesh, patents are in force in many other countries including Brazil and Indonesia. …
“The possibilities for providing high-level intensive care are limited, so saving more lives of people with severe and critical infections relies heavily on having access to affordable medicines that we can add to the steroids, oxygen and close supportive care that we already provide in our projects. As new treatments emerge, it will be simply inhumane if they remain unavailable in resource-limited settings, just because they are patented and too expensive.”
The WHO added what it said were “lifesaving” interleukin-6 receptor blockers to its list of treatments for COVID-19 last July. It recommended the use of corticosteroids in September 2020.
In recent weeks, government regulators have also approved new oral treatments for the disease, including Paxlovid, Pfizer’s antiviral pill, which showed close to 90 percent efficacy in preventing hospital admission and death in high-risk patients. It also retained its effectiveness with Omicron, the company said.

WHO recommends two new drugs to treat COVID-19 (14/01/2022) | @WHO

Omicron: What you need to know about the COVID variant (01/18/2022) | @CBSnews
Will current medicines still work?
Spokespeople for Merck and Pfizer both say they believe their antiviral pills, which have been hailed as potential game-changers in the fight against the virus, will likely remain effective against Omicron. Pfizer’s drug, Paxlovid, and Merck’s, molnupiravir, were both granted FDA emergency use authorization in December.
Of the monoclonal antibody treatments currently authorized for COVID-19, only two drugs — one made by AstraZeneca and one from GlaxoSmithKline and Vir Biotechnology — appear to remain effective against Omicron.
The Biden administration recently lifted curbs on the distribution of monoclonal antibodies from Regeneron and Eli Lilly, pointing to “significant variability” in Omicron’s prevalence around the country and new guidelines published by the National Institutes of Health on prioritizing limited supplies of the drugs.
Regeneron said on December 16 it was working on “next generation” monoclonal antibodies that could effectively treat Omicron cases, acknowledging that its current antibodies “have diminished potency against Omicron.”

2 charts show how Omicron symptoms differ from Delta and past coronavirus variants (01/14/2022) | @businessinsider
Coronavirus Omicron 2 charts @businessinsider

 

 

 

 

 

 

What are the symptoms of Omicron? (w YouTube; 18/01/2022) | ZOE
… The top 5 symptoms in both periods were: 1. runny nose; 2. headache; 3. fatigue (mild or severe); 4. sneezing; 5. sore throat
…the PREDICT program… people who ate a high-quality diet, rich in plant-based foods, were 10% less likely to get COVID-19 and 40% less likely to get severe COVID-19 requiring treatment in the hospital. …

Omicron Variant: What You Need to Know | @CDCgov
Coronavirus Self-Checker | @CDCgov
Coronavirus: 14 Omicron symptoms ranked from most to least prevalent (01/19/2022) | @timesofindia
Why ‘mild’ COVID symptoms aren’t what you think they are (01/18/2022) | @Deseret
Am I asymptomatic, or do I just really not want to have Covid-19? A guide. (01/18/2022) | @voxdotcom
Here’s One Early Omicron Symptom You Should Watch for as Infections Climb (w Video; 01/15/2022) | @nbcchicago
Omicron: What We Know About the New Coronavirus Variant (01/03/2022) | @nytimes

US faces wave of omicron deaths in coming weeks, models say (01/18/2022) | @AP
COVID-19 Scenario Modeling Hub

Benelux ベネルクス Vol.6(Belgium ベルギー Vol.2)

続き cont.


https://twitter.com/UmicoreGroup/status/1479087610064691209


https://twitter.com/UmicoreGroup/status/1471491248766676997


https://twitter.com/ConDino007/status/1468868582880817157


https://twitter.com/mart_di_be/status/1468538437334716418

https://twitter.com/SolvayGroup/status/1483106846701465603


https://twitter.com/SolvayGroup/status/1478350510851825667
https://twitter.com/SolvayGroup/status/1479815175159136266
https://twitter.com/SolvayGroup/status/1480962714457550850
https://twitter.com/SolvayGroup/status/1481264723249307652


https://twitter.com/environment/status/1227959461991604230


 https://twitter.com/ICIJorg/status/1445434840355151875


https://twitter.com/eliacorporate/status/1387368413648068609


https://twitter.com/eliacorporate/status/1415340781414588423
https://twitter.com/eliacorporate/status/1414525014532149252
https://twitter.com/eliacorporate/status/1408430714144624651
https://twitter.com/eliacorporate/status/1407325154934394884
https://twitter.com/eliacorporate/status/1405907349735358468
https://twitter.com/eliacorporate/status/1404749342834147329
https://twitter.com/eliacorporate/status/1403008383171633153
https://twitter.com/eliacorporate/status/1395267592902881281
https://twitter.com/eliacorporate/status/1394918540625563650
https://twitter.com/eliacorporate/status/1383091894801076224


https://twitter.com/eliacorporate/status/1360269017685057539
https://twitter.com/eliacorporate/status/1357004527057195010


https://twitter.com/eliacorporate/status/1347064629663567876


https://twitter.com/RenewablesGrid/status/1440232745376964611
https://twitter.com/RenewablesGrid/status/1435145774933938177


https://twitter.com/WABCO/status/1455482643886313477


 https://twitter.com/DhanValue/status/1480364220118040576

Benelux ベネルクス Vol.5(Belgium ベルギー Vol.1)

All the below tweets/links are in English.

取り急ぎ以下貼っておきます。

Belgium Vol.8 (mtm_kuleuven, BrusselsTimes, etc.)

Benelux Vol.6 (Netherlands Vol.12 / Belgium Vol.7)

以下、順に、
@KU_Leuven,@NatGeoNL,@stadleuven、@leuveninnovate、@BrusselsTimes
Belgium8 BigBang theory city @KU_Leuven,@NatGeoNL,@stadleuven
Belgium8 genetic passport bees @leuveninnovate
Belgium8 Hidden Belgium The century-old mustard shop @BrusselsTimes

 

 

 

 

 

 

 

 

 

 

 

企業名などを入力検索して出て来たツイート


https://twitter.com/NYSE/status/1482110033345323012


https://twitter.com/WWFLeadWater/status/1455879144454205445
https://twitter.com/OvieNews/status/1381928723453214722


https://twitter.com/AnheuserBusch/status/1459190012902322182


https://twitter.com/BelgiumAtlanta/status/1049998598656720896


https://twitter.com/AgeasGroup/status/1463137337869803531
https://twitter.com/AgeasGroup/status/1450013870060359681
https://twitter.com/AgeasGroup/status/1436313016560201754


https://twitter.com/AgeasGroup/status/1397877150435446789
https://twitter.com/AgeasGroup/status/1394220561530753025
https://twitter.com/AgeasGroup/status/1390254754148802561


https://twitter.com/ficompass/status/1122884790036893696


https://twitter.com/Greenpeaceafric/status/993779926565359616

Northern Europe 北欧 Vol.8(Sweden スウェーデン Vol.3)

続き cont.


https://twitter.com/Spotify/status/1474076063550554112


https://twitter.com/Spotify/status/1474409538304364547


https://twitter.com/coldplay/status/1481370018524934156

以上です。

Northern Europe 北欧 Vol.7(Sweden スウェーデン Vol.2)

続き cont.


https://twitter.com/IKEA_Campaign/status/1468097943714549761
 https://twitter.com/HuffPostJapan/status/1479374845066588160


https://twitter.com/hm/status/1403037133246509056